Macrolide and lincosamide resistance in staphylococcal clinical isolates in Nablus, Palestine

Motasem Almasri1, Nael Abu Hasan1, Naela Sabbah1

  • 1Department of Biology & Biotechnology, Faculty of Science, An-Najah National University, Nablus, Palestine.

Abstract

Insights

High rates of macrolide resistance, including inducible phenotypes, were found in staphylococcal isolates. This highlights the need for careful antibiotic selection in treating staphylococcal infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Macrolide and lincosamide antibiotics are crucial for treating staphylococcal infections, particularly in penicillin-allergic individuals.
  • Evaluating resistance patterns is essential for effective treatment strategies.

Purpose of the Study:

  • To determine the prevalence of resistance to macrolide and lincosamide antibiotics in staphylococcal isolates.
  • To investigate the mechanisms and genetic basis of erythromycin resistance.

Main Methods:

  • Collected 200 staphylococcal clinical isolates.
  • Determined minimal inhibitory concentrations (MICs) for erythromycin and clindamycin using agar dilution.
  • Performed erythromycin-clindamycin induction tests and PCR for resistance genes.

Main Results:

  • Erythromycin resistance was 65.5% and clindamycin resistance was 20.5%.
  • Resistance mechanisms included efflux (50.4%) and target site modification (49.6%).
  • Inducible resistance was observed in 19.1% of erythromycin-resistant isolates, with genes like erm(C) and msr(A) frequently detected.

Conclusions:

  • Staphylococcal isolates exhibit high macrolide resistance rates and a significant prevalence of inducible resistance phenotypes.
  • Resistance rates may vary across different patient demographics and specimen sources, necessitating tailored treatment approaches.